Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...
Zacks.com on MSN3hOpinion
5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era
The biotech industry has declined since Donald Trump’s election victory. This was mainly because Trump nominated Robert F.
Chocolate Recalled in 3 States Over Possible 'Life-Threatening' Reaction
A chocolate-covered pretzel product is being recalled in three states due to the presence of an undeclared milk allergen.
Rolling Out4h
Life-threatening allergen found in nation’s favorite snack
Urgent class 1 recall affects thousands of Lay's Classic Potato Chips bags due to undeclared milk allergen, posing severe health risks to sensitive consumers.
Axsome Therapeutics’ Promising Market Potential Following FDA Approval of Symbravo for Acute Migraine
Analyst Vikram Purohit of Morgan Stanley maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), retaining the price target of ...
Antigua Observer Newspaper8h
Lay’s potato chips recall now at highest risk level
The Prices and Consumer Affairs Division advises consumers of an ongoing recall of Lay's classic potato chips over undeclared ...
Journey Medical: FDA Approval For Emrosi Makes This An Exciting Stock
The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.
Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook
2025 is a truly pivotal year, expected to end with the commercialization of our first AI-based Software as a Medical Device, ...